From July 9-11, Sankara Nethralaya's Retina Summit 008 attracted over 200 budding vitreoretinal surgeons nationwide. The event’s theme, “Crisis Control,” focuses on preventing and managing medical and surgical complications in retinal practice.
Key Takeaways
- Summit theme is ‘Crisis Control’
- Over 200 aspiring vitreoretinal surgeons participating
- Steve Charles delivered the keynote address
Sankara Nethralaya’s Department of Vitreoretinal Services hosted its annual scientific gathering, Retina Summit 008, from July 9 to 11. The three‑day event is set to bring nearly two hundred young vitreoretinal surgeons from across India together, offering exposure to cutting‑edge technologies and surgical techniques.
Summit Theme: Crisis Control
The chosen theme, “Crisis Control,” underscores the importance of preventing, early detecting, and efficiently managing medical and surgical complications in retinal practice. Given the intricate nature of retinal disorders, this focus is especially pertinent for surgeons at the early stage of their careers.
Pre‑Conference Programme
On July 9, a dedicated pre‑conference programme featured intensive lectures and hands‑on workshops. Veteran trainers covered micro‑surgical techniques, intravitreal injections, and postoperative care, equipping participants with practical skills to handle real‑world clinical scenarios.
Main Scientific Sessions & Keynote Speaker
The core scientific sessions on July 10 and 11 showcased experts from Sankara Nethralaya and leading eye hospitals nationwide. The summit’s keynote address was delivered by renowned vitreoretinal surgeon Steve Charles, who highlighted global advancements in retina surgery and best practices for patient safety.
Future Impact
Beyond knowledge exchange, such summits elevate the standards of vitreoretinal surgery in India. Attendees are expanding professional networks, paving the way for collaborative research and patient‑centric care models. Many surgeons plan to integrate “Crisis Control” protocols into their clinics, promising improved outcomes for retinal patients.